Discover 532 paid clinical trials in Hershey, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 532
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Exton PA, Media PA, Langhorne PA, Bethesda MD,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase 3, Recruiting
TERPS Trial for de Novo Oligometastic Prostate Cancer
for
Prostate Cancer, Oligometastatic Disease
Location: Bel Air MD, Baltimore MD, Columbia MD, Glen Burnie MD,
Sponsor: University of Maryland, Baltimore
Sex: Male
Age: 18+
Code: NCT05223803
Phase 2, Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for
Graves' Disease
Location: Pottstown PA, Newark DE, Baltimore MD,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT06727604
Phase 2, Recruiting
Tu Salud (Your Health) Randomized Control Study in Patients With Diabetes Using a Mobile App.
for
Diabetes Mellitus
Location: West Chester PA
Sponsor: LifeScan
Sex: All
Age: 18+
Code: NCT03556605
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
for
Hematologic Disorder, Bleeding Disorder,
Location: Wilmington DE, Baltimore MD, Philadelphia PA,
Sponsor: American Thrombosis and Hemostasis Network
Sex: All
Age: 0+
Code: NCT04398628
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
for
Focal Segmental Glomerulosclerosis
Location: Exton PA, Baltimore MD, Bethlehem PA, Arlington VA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 12+
Code: NCT07220083
Phase 3, Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for
End Stage Kidney Disease
Location: Exton PA, Bethlehem PA, Fairfax VA, Eatontown NJ,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT05485961
Phase 2, Phase 3, Recruiting
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
for
Advanced Lung Non-Small Cell Carcinoma,
Location: Hazleton PA, Allentown PA, Paoli PA, Media PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03191149
Phase 2, Recruiting
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
for
Castration-Resistant Prostate Carcinoma,
Location: Hazleton PA, Allentown PA, Elkton MD, Newark DE,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT06470243
Phase 3, Recruiting
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors